Traynor Capital Management Inc. Boosts Holdings in Amgen, Inc.
Traynor Capital Management Inc. raised its stake in Amgen, Inc. by 8.1% during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 11,408 shares of the medical research company's stock after buying an additional 855 shares during the period.
from Biotech News
Комментариев нет:
Отправить комментарий